Chad M. Robins, CEO and Chairman at Adaptive Biotechnologies Corp (ADPT), sold 118,020 shares at $12.46 ($1.2M) on 2022-03-09, disclosed to the SEC on 2022-03-09.
Open-market sale of $1.2M ADPT by CEO and Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.53 | 14,315 | $165K | 13.4% |
| 2 | $11.53 | 14,315 | $165K | 13.4% |
| 3 | $12.22 | 500 | $6K | 0.5% |
| 4 | $6.32 | 14,815 | $94K | 7.6% |
| 5 | $11.38 | 14,815 | $169K | 13.7% |
| 6 | $11.38 | 14,815 |
| $169K |
| 13.7% |
| 7 | $6.32 | 14,815 | $94K | 7.6% |
| 8 | $12.46 | 14,815 | $185K | 15.0% |
| 9 | $12.46 | 14,815 | $185K | 15.0% |
| Total | $10.42 avg | 118,020 | $1.2M | 100% |
| Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |
| ADPT | SELL | 2026-03-03 | $8.3M | — | Filing → |
| ADPT | SELL | 2026-02-04 | $2.3M | — | Filing → |